Our MR-derived protective association suggests PDCD1LG2 may exert tumor-suppressive effects in GC pathogenesis under certain genetic or microenvironmental contexts, challenging conventional oncogenic paradigms and warranting mechanistic exploration. The gene discussed is NR3C2; the disease is gastric cancer.